Home » Newsletters » BioWorld Science

BioWorld Science

March 9, 1998

View Archived Issues

Effects of EAA receptor antagonists on morphine tolerance and dependence

Company Profile: Andrx

KBR-7943, a novel Na+/Ca2+ exchange inhibitor

Benefits of finasteride in patients with benign prostatic hyperplasia

JTV-506, a potential antianginal agent

Beneficial effects of aspirin on endothelial dysfunction in patients with atherosclerosis

The role of ETA and ETB receptor subtypes in human blood vessels

DepoTech: Q4 and year-end 1997 highlights

Neurex: year-end 1997 highlights

Lilly antifolate evaluated in phase II

Favorable phase I results obtained with G-3139 in NHL

S-1 demonstrates excellent antitumor activity in phase II

Overview of preclinical and clinical evaluation of Russian nitrosourea

Viracept approved in Japan

Evidence of clinical efficacy of ukrain in colorectal cancer

Entropin goes public

Anticancer imidazoles from Merck & Co.

DepoCyt FDA review period extended in order to review additional patient data

Roche finalizes Corange acquisition

Once-a-day Cozaar introduced in Canada

Ritonavir in advanced HIV-1 disease

Antithromboxane therapy leads to clinical benefit in type II diabetics

New cisapride formulation introduced in U.K.

DepoMed, R.W. Johnson sign research agreement